SUBSCRIBE
SUBSCRIBE
News   FDA

India Dr. Reddy’s Laboratories Ltd.'s Gets FDA Nod for Osteoporosis Drug

August 11, 2008 | 
1 min read
MUMBAI, Aug 11 (Reuters) - Indian drugmaker Dr. Reddy's Laboratories Ltd has received approval from the U.S. Federal Drug Administration to make and market alendronate sodium tablets, the regulator's website showed.
FDA Approvals Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Man walking on a long wavy path with flag at the end, persistence, determination and ultimate business success - 3D Render
Rare disease
UniQure Eyes Phase 3 for Huntington’s Gene Therapy Despite Makary’s Apparent Criticism
March 2, 2026
 · 
3 min read
 · 
Heather McKenzie
Racing Cars at the finish line
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
March 2, 2026
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: BMS, GSK, Aldeyra and More
March 2, 2026
 · 
4 min read
 · 
Tristan Manalac
Borrow money from friend, debt and loan, incentive or bonus payment, credit or lending concept, businessman hand giving money banknote to friend's hand.
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
February 27, 2026
 · 
1 min read
 · 
Annalee Armstrong